The naive CD4+CD45RA+ cells from RR MS patients, which were transfected with siRNA IRF4, exhibited significant inhibition of the induction of IL-1RI, IRF4, RORc, IL-17A, IL-17F, IL-21, and IL-23R gene expression (Figure 6). The gene discussed is IRF4; the disease is myeloid sarcoma.